July 5 2016
The proliferation of publications and recent recommendations on visual inspection (USP vs European Pharmacopeia, PDA, ACE ...) highlights, if we dare this term, the particles as constant elements in injectable products, which gives us to you about it, a recognized legitimacy for almost 5 years through Common Interest Group, which is attached to this subject thoroughly.
If the visual inspection is a detection means increasingly framed by practical and detailed harmonized specifications, it is not the same for prevention that takes fluctuating aspects of components, production methods, the risk analyzes that give weight to the final visual inspection.
The Forum A3P Visible Particles remains a privileged moment qu'A3P organizes with three clear objectives:
1. Demonstrate a comprehensive approach to management of the presence of particles is required and practical reviews are underway,
2. Specify collaborative work between users and suppliers, testing laboratories and development,
3. Characterize particles to better identify their sources.
This convergence point to be held in Vaudreuil on July 5 meets your permanent interrogations, those that you share with your A3P through comparative studies, meetings remotely or indispensable experience feedback.
The program is offered constantly relies on these three pillars and you will provide technical data and processes to address better to the presence of undesirable particles visible.
Among our strengths, we we question and interrogate the Occupation on the relevance of the test Knapp and the role of NQA / AQL on particle characterization, based on the origin of components or processes. A place will be kept to a forum question / answer that will be transcribed for your own application within your sites.
The trust that we keep this cross-fertilization still brand this year our presence and expertise we would like to share you with cordiality and excellence.
Forum A3P Visible Particles program
Flag Erl - THE VAUDREUIL - France
|08h30||Participants registration and coffee|
Gérard Ecotière - A3P Association President
||ICG Particles Elastomers - Review and Prospects
Cyril Thouseau - Sanofi Pasteur
||The particle too: reduce the risk of its presence on the markets by the automatic mirage
Jean-Michel Tasserit - Aspen Pharma
||Benefits and challenges of the visual inspection of particles: Key Challenges for the qualification of operators
Sonia Kasperowiscz - GSK
|11h30||Proceedings in Automated Visual Inspection of hard to inspect container type like BFS Products
Heino Prinz - Kocher Plastik
||Visual inspection - Kit Daily - Reclassification - Periodic Maintenance Control
Aurélien Genet - GSK
|14h00||Particle Detection by means clustering of X-Ray
Roland Koch - Wilco
||Particulate contamination and market recalls in injectable.
Patrick Turlier - GSK
Round table :
||Q / A Forum|
|16h45||Forum A3P end Visible Particles|